September 26, 2007 - Diagnostic software maker Rcadia Medical Imaging Ltd. received a second FDA clearance to market its COR analyzer family of products, which assists in triaging patients for coronary artery disease (CAD).
The new approval includes segmentation of the coronary tree with no human intervention and automatic detection of pathologies in the main coronary arteries.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now